A Retrospective Evaluation of Conjunctivitis and Keratitis Among Individuals with Moderate-to-severe Atopic Dermatitis Treated with Dupilumab in the United States (US)

14/12/2021
02/07/2024
EU PAS number:
EUPAS42461
Study
Finalised
Documents
Study protocol
Study results
Study results
English (146.94 KB - PDF) View document
Study report
Other information